ENDOMETRIAL CARCINOMA

Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL CARCINOMA trials appear

Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 4 Not yet finished but already full! 14 Completed 2 Terminated 1

Cancer combo trial ends early: what happened?

Disease control Terminated

This study tested a combination of two drugs, futibatinib and pembrolizumab, in people with advanced endometrial cancer that had spread and was not responding to standard treatments. The goal was to see if the combination could shrink tumors or slow the disease. Only 9 people too…

Matched conditions: ENDOMETRIAL CARCINOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 15, 2026 11:53 UTC

ENDOMETRIAL CARCINOMA

Get alerted when new ENDOMETRIAL CARCINOMA trials appear

Cancer combo trial ends early: what happened?